✦ LIBER ✦

The continuous arterial infusion of 5-fluorouracil as a therapeutic adjunct in the treatment of advanced carcinoma of the bladder and prostate. A preliminary report

✍ Scribed by James E. Nevin III; Irving Melnick; John T. Baggerly Jr.; Allen Hoffman; Ralph R. Landes; Charles Easley

Publisher: John Wiley and Sons
Year: 1973
Tongue: English
Weight: 779 KB
Volume: 31
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197301)31:1<138::aid-cncr2820310118>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brachytherapy and continuous infusion 5-

Brachytherapy and continuous infusion 5-fluorouracil for the treatment of locally advanced, lymph node negative, prostate cancer: A phase I trial

✍ William A. See; Robert Dreicer; James A. Wheeler; Paula K. Forest; Stefan Loenin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

BACKGROUND. 5-fluorouracil (5-FU) is a known radiosensitizer that enhances efficacy, in vivo and in vitro, when administered during radiotherapy. The following study was performed to evaluate the toxicity of continuous infusion 5-FU administered concomitant with brachytherapy in patients with locall

Paclitaxel, carboplatin, and long-term c

Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas : Results of a Phase II trial

✍ John D. Hainsworth; Howard A. Burris III; Anthony A. Meluch; Margaret N. Baker; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Continuous-infusion cisplatin, 5-fluorou

Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer

✍ Thomas J. Lynch Jr.; John R. Clark; Leslie A. Kalish; Barbara G. Fallon; Anthony 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

Cisplatin, continuous-infusion 5-fluorou

Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung

✍ Catherine A. Wheeler; Lawrence N. Shulman; Steven E. Come; Lowell E. Schnipper; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 2 views

Forty-one patients with unresectable non-small cell carcinoma of the lung (NSCCL) were treated with cisplatin 20 mg/m2/d for 5 days as a daily bolus injection, 5-fluorouracil 800 mg/m2/d by continuous infusion for 5 days, and intermediate-dose methotrexate 200 mg/m2 on days 15 and 22 of a 28-day cyc

Irinotecan and chronomodulated infusion

Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma : A Phase I study

✍ Carlo Garufi; Luigi Dogliotti; Rita M. D'Attino; Marco Tampellini; Anna M. Asche 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

Interim results of a randomized trial of

Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix

✍ Kenneth B. Roberts; Nelson Urdaneta; Raul Vera; Andres Vera; Enrique Gutierrez; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 380 KB 👁 3 views

The purpose of this study was to determine the efficacy of mitomycin C as an adjunct to radiotherapy for the treatment of locally advanced cervix cancer. Patients with squamous-cell carcinoma of the cervix, stages IB2-IVA, were randomized to receive radiotherapy alone or radiotherapy with concomitan